GGrantIndex
← Leaderboards

James E Udelson

Tufts Medical Center

$1,950,660
Attributed
$1,950,660
Total exposure
6
Grants
1
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $797.3K · FY200508
$1M$750K$500K$250K$0
'05
'06
'07
'08

Funding mix

By agency

NIH$4,068,173 · 7

By mechanism

R01$2,117,513 · 3
P50$1,739,988 · 1
U01$205,913 · 1
M01$4,759 · 2

Top collaborators

No co-investigators on record.

Most similar at Tufts Medical Center

Same institution · by research overlap

Others in their field

Top investigators on “Myocardial Infarction

Research focus

Myocardial InfarctionClinical ResearchHuman SubjectHormone Regulation /Control MechanismHuman Therapy EvaluationPostmenopauseFemaleCardiovascular FunctionEstrogensEstrogen ReceptorsClinical TrialsMyocardial Ischemia /HypoxiaHeart VentricleArrhythmiaHeart ContractionOsteoporosisGenetic MarkersChemopreventionGenetic PolymorphismBaroreceptorsEstrogen InhibitorAutonomic ReflexCardiovascular Disorder ChemotherapyGenotype

Grant awards (21)

Myocardial Viability and Remodeling in the OAT$140,070
R01 · FY2008 · HL · contact PI
Myocardial Viability and Remodeling in the OAT$188,457
R01 · FY2007 · HL · contact PI
Myocardial Viability and Remodeling in the OAT$515,980
R01 · FY2006 · HL · contact PI
Myocardial Viability and Remodeling in the OAT$190,327
R01 · FY2006 · HL · contact PI
LV Function Assessment Core Lab for IMMEDIATE Trial$90,975
U01 · FY2006 · HL · contact PI
Myocardial Viability and Remodeling in the OAT$540,654
R01 · FY2005 · HL
LV Function Assessment Core Lab for IMMEDIATE Trial$94,082
U01 · FY2005 · HL
SELECTIVE ESTROGEN RECEPTOR MODULATION: EFFECTS IN POST-MENOPAUSAL WOMEN$603
M01 · FY2005 · RR
Foreign Cohort: Myocardial Viability and Remodeling in the OAT-NUC$0
R01 · FY2005 · HL
Domestic Cohort: Myocardial Viability and Remodeling in the OAT-NUC$0
R01 · FY2005 · HL
Myocardial Viability and Remodeling in the OAT$542,025
R01 · FY2004 · HL
ESTROGEN RECEPTOR MODULATION--EFFECTS IN POST MENOPAUSAL WOMEN$230,991
P50 · FY2004 · HL
LV Function Assessment Core Lab for IMMEDIATE Trial$20,856
U01 · FY2004 · HL
Selective Estrogen Receptor Modulation: Effects in Women$4,156
M01 · FY2004 · RR
ESTROGEN RECEPTOR MODULATION--EFFECTS IN POST MENOPAUSAL WOMEN$228,923
P50 · FY2003 · HL
ESTROGEN RECEPTOR MODULATION--EFFECTS IN POST MENOPAUSAL WOMEN$442,783
P50 · FY2002 · HL
Estrogen receptor modulation--Effects in postmenopausal women following myocardia$0
M01 · FY2002 · RR
ESTROGEN RECEPTOR MODULATION--EFFECTS IN POST MENOPAUSAL WOMEN$439,023
P50 · FY2001 · HL
Estrogen receptor modulation--Effects in postmenopausal women following myocardia$0
M01 · FY2001 · RR
ESTROGEN RECEPTOR MODULATION--EFFECTS IN POST MENOPAUSAL WOMEN$398,268
P50 · FY2000 · HL
Estrogen receptor modulation--Effects in postmenopausal women following myocardia$0
M01 · FY2000 · RR